​Second Dengue Vaccine

  • On 10th May, 2024, a new vaccine for dengue, TAK-003, received prequalification from the World Health Organization (WHO).
  • Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.
  • WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity.
  • Takeda's vaccine demonstrated 84% efficacy against hospitalization and 61% efficacy in symptom ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

News Snippets